Hospital for Special Surgery, New York
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Hospital for Special Surgery, New York sits in the top decile of US sponsors by registered trial count (#155 of 15,742 sponsors by registered trial count).
Hospital for Special Surgery, New York: 194 sponsored US clinical trials, 35 recruiting.
Hospital for Special Surgery, New York sponsors 194 registered US clinical trials on ClinicalTrials.gov, 35 of them currently recruiting, and 123 completed. 58 of these trials are in Phase 3-4 (later-stage) and 19 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use, with 7 trials.
Top-decile sponsor footprint
Hospital for Special Surgery, New York ranks in the top decile of sponsors by registered trial count (#155 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
123 of 145 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
194 total, page 4 of 4
Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
NCT01670565
Effect of Local Anesthetic Dose on Interscalene Block
NCT01701115
Comparing Subsartorial Saphenous Nerve Blocks With and Without Dexamethasone for Anterior Cruciate Ligament Reconstruction
NCT01586806
Saphenous Nerve Block vs. Femoral Nerve Block for Total Knee Arthroplasty
NCT01505374
Study of Melatonin on Sleep, Pain, and Confusion After Joint Replacement Surgery
NCT01505465
Analgesia After Total Hip Arthroplasty: Peri-Articular Injection Versus Epidural Patient Controlled Analgesia (PCA)
NCT01658072
Interscalene Dynamometer Pilot Study
NCT01550952
Study to Find Optimal Dose of Local Spinal Anesthetic (Mepivacaine) Combined With Narcotic (Fentanyl) For Knee Surgery
NCT01701102
Doppler Ultrasound Following Unicondylar Knee Replacement to Determine the Incidence of Postoperative DVT
NCT02148757
Effects of Pregabalin on Pain After Total Knee Arthroplasty
NCT01333956
Study of Tocilizumab to Treat Polymyalgia Rheumatica
NCT01396317
Ischemic Preconditioning in Total Knee Arthroplasty
NCT01333969
MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex
NCT01450397
Saphenous Nerve Block Versus Femoral Nerve Block for Total Knee Arthroplasty
NCT01333943
Effect of Low Dose Corticosteroids on Perioperative Markers of Thrombosis and Fibrinolysis in Total Knee Arthroplasty
NCT01815918
A Prospective Randomized Study on the Clinical Benefits of OrthoPAT Drains
NCT02286102
Conventional Alignment System Versus Surgical Navigation System in Total Knee Arthroplasty
NCT01797731
Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine
NCT01277159
Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
NCT01475149
The Use of Evicel to Reduce Blood Loss in Total Knee Replacement Surgery
NCT01235715
Nilotinib in the Treatment of Systemic Sclerosis
NCT01166139
Lumbar Plexus Block for Postoperative Pain Control After Hip Arthroscopy. A Randomized Controlled Trial
NCT01286805
Vitamin D and Functional Outcomes After Total Hip Arthroplasty (THA)
NCT01397383
Analgesia After Total Knee Arthroplasty: Peri-Articular Injection Versus Epidural + Femoral Nerve Blockade
NCT01335542
Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy
NCT00878228
Steroids in Bilateral Total Knee Replacement
NCT01399268
Pregabalin for the Treatment of Pain After Posterior Spinal Fusions
NCT01366196
Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients
NCT00674297
The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery
NCT00990288
A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome
NCT00537290
Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
NCT00555581
A Study of Hyaluronan for the Treatment of Osteoarthritis in the Thumb
NCT00398866
Unipedicular vs. Bipedicular Kyphoplasty for the Treatment of Osteoporotic Vertebral Fractures
NCT01383616
Prospective Assessment of the Efficacy of Hyaluronate Knee Injections in Patients With Osteoarthritis
NCT00323778
Memory and Attention Problems in Lupus: New Treatment Trial With Modafinil
NCT00297284
A Pre-Operative Screening Questionnaire (AMS-Q) for Ambulatory Orthopedic Surgery Patients
NCT00337584
Asthma Patient Education in the Emergency Room
NCT00110409
An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study
NCT00198029
Bone Tunnel Widening Following ACL Reconstruction
NCT00198042
Expectations, Satisfaction and Quality of Life in Total Hip Arthroplasty
NCT00197990
Addressing Patients' Expectations of Total Hip Arthroplasty in a Randomized Trial
NCT00198003
Addressing Patients' Expectations of Total Knee Arthroplasty in a Randomized Trial
NCT00197977
A Randomized Trial to Improve Quality of Life Outcomes in Asthma Patients
NCT00197964
Job Adaptation in Patients With Rheumatoid Arthritis
NCT00412399
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 14 |
| Phase 3 | 8 |
| Phase 4 | 50 |
Therapeutic Areas
Where Hospital for Special Surgery, New York enrollment is open (later-stage tilt)
35 recruiting of 194 indexed (18% open); 123 completed (63%).
Phase mix: 58 late (III/IV) vs 19 early (I/II) (later-stage heavy).
Top condition: Opioid Use (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Hospital for Special Surgery, New York: open-pipeline peers nationwide
Peers matched on 194 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Hospital for Special Surgery, New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 194 trials (± recruiting share)
- Genzyme, a Sanofi Company · 196 trials · 2% recruiting
- Vertex Pharmaceuticals Incorporated · 191 trials · 10% recruiting
- Vanderbilt-Ingram Cancer Center · 189 trials · 15% recruiting
- Nationwide Children's Hospital · 188 trials · 15% recruiting
Sponsors near 18% open enrollment (± trial volume)
- George Washington University · 18% recruiting · 133 trials
- West Virginia University · 18% recruiting · 122 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
Related
What to do with this Hospital for Special Surgery, New York page
194 registered trials is a research-attention snapshot, not an endorsement of Hospital for Special Surgery, New York or any single study.
- 35 of Hospital for Special Surgery, New York's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use is the condition Hospital for Special Surgery, New York studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Hospital for Special Surgery, New York pipeline card: 194 registered trials from official public datasets.Report a data error.